![](/img/cover-not-exists.png)
Cost-effectiveness of exenatide versus insulin glargine in Spanish patients with obesity and type 2 diabetes mellitus
Gordon Goodall, María Costi, Louise Timlin, Jesús Reviriego, José Antonio Sacristán, Jayne Smith-Palmer, Tatiana DillaVolume:
58
Year:
2011
DOI:
10.1016/j.endoen.2011.04.002
File:
PDF, 225 KB
2011